19th Tetrahedron Symposium


Matthew Fuchter, Imperial College London, UK

Dr Matthew Fuchter is a Reader in Chemistry, co-Director of the MRes postgraduate course in Drug Discovery, and co-Director of a newly established Centre for Drug Discovery Science at Imperial College London. He is a member of multiple multidisciplinary centres of excellence at Imperial including the Institute of Chemical Biology, the Imperial College Network of Excellence in Malaria, and the Cancer Research UK Centre of Excellence. His research concerns the development of chemistry-led approaches to interrogate function in chemistry, materials and medicine. In the areas of medicinal chemistry and chemical biology, a key focus is the study of transcriptional targets. He is heavily involved in translational activities across his scientific portfolio and is an inventor of ICEC0942/CT7001; a clinical candidate undergoing early clinical trials for the treatment of multiple cancers.

Homepage: http://www.imperial.ac.uk/fuchter-group
LinkedIn: http://www.linkedin.com/in/matt-fuchter-b807bb3